Companies: 49,247 Total Market Cap: 132748422762186.78

The IBN SINA Pharmaceutical Industry PLC

DSE-IBNSINA
Pharmaceutical Preparations
Rank #26415
Market Cap 72.75 M
Volume 2,548
Price 2.34
Change (%) 1.06%
Country or region Bangladesh Bangladesh

The IBN SINA Pharmaceutical Industry PLC's latest marketcap:

72.75 M

As of 05/21/2025, The IBN SINA Pharmaceutical Industry PLC's market capitalization has reached $72.75 M. According to our data, The IBN SINA Pharmaceutical Industry PLC is the 26415th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 72.75 M
Revenue (ttm) 96.55 M
Net Income (ttm) 5.18 M
Shares Out 31.24 M
EPS (ttm) 0.17
Forward PE 12.32
Ex-Dividend Date 10/28/2024
Earnings Date 04/24/2025
Market Cap Chart
Data Updated: 05/21/2025

The IBN SINA Pharmaceutical Industry PLC's yearly market capitalization.

The IBN SINA Pharmaceutical Industry PLC has seen its market value grow from 7.62 B BDT to 8.90 B BDT since 2020, representing a total increase of 16.68% and an annual compound growth rate (CAGR) of 3.58%.
Date Market Cap(BDT) Change (%)
05/21/2025 8.90 B 0%
12/30/2024 8.96 B 0.07%
12/28/2023 8.95 B 0%
12/29/2022 8.95 B 5.64%
12/30/2021 8.48 B 11.19%
12/30/2020 7.62 B

Company Profile

About IBN SINA Pharmaceutical Industry PLC

IBN SINA Pharmaceutical Industry PLC is a leading pharmaceutical company based in Bangladesh, operating both domestically and internationally. Established in 1983 and headquartered in Dhaka, the company specializes in the production and sale of a diverse range of pharmaceutical products.

Product Portfolio

The company offers a comprehensive selection of pharmaceutical drugs in various forms, including:

  • Solid Dosage Forms: Tablets and capsules
  • Parenteral Products: Ampoules and vials
  • Liquid Dosage Forms: Syrups, solutions, suspensions, and powder for suspension (dry syrups)
  • Sterile Ophthalmic Products: Eye drops, creams, ointments, gels, and sachets

Therapeutic Categories

IBN SINA provides a wide array of therapeutic products, covering:

  • Analgesic & Anti-inflammatory
  • Anti-allergic & Ocular
  • Anti-diabetic & Cardiovascular
  • Antibacterial & Antiviral
  • Gastrointestinal & Anti-ulcerant
  • Hormonal & Multivitamin supplements
  • Neurological & Psychiatric agents
  • Urological & Respiratory preparations

Additional Offerings

Beyond conventional pharmaceuticals, the company also specializes in:

  • Herbal and Unani products
  • Active Pharmaceutical Ingredients (APIs)
  • Natural medicines
  • Packaging solutions (plastic bottles, tubes, laminated tubes)
Frequently Asked Questions

As of 05/21/2025, The IBN SINA Pharmaceutical Industry PLC (including the parent company, if applicable) has an estimated market capitalization of $72.75 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

The IBN SINA Pharmaceutical Industry PLC global market capitalization ranking is approximately 26415 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 1983
IPO Date n/a
Employees 4,200
CEO A. K. Sadrul Islam
Sector
Industry Pharmaceutical Preparations
Address Tanin Center
Dhaka, 1207
Bangladesh
Website https://www.ibnsinapharma.com
People Also Watch
Ipsen S.A.
138.71 1.06%
Krka, d. d.
210.69 1.06%
BUD-RICHTER
29.22 1.06%
Hugel
262.42 1.06%